Thermo Fisher Scientific Inc. (BMV:TMO)
Mexico · Delayed Price · Currency is MXN 9,745.73
-201.25 (-2.02%)
At close: Oct 10, 2025
Thermo Fisher Scientific Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Net Income | 6,583 | 6,338 | 5,955 | 6,960 | 7,728 | 6,377 | Upgrade |
Depreciation & Amortization | 2,872 | 3,108 | 3,406 | 3,381 | 2,592 | 2,325 | Upgrade |
Stock-Based Compensation | 303 | 301 | 278 | 307 | 230 | 196 | Upgrade |
Other Adjustments | -654 | -701 | -696 | -445 | 310 | -214 | Upgrade |
Change in Receivables | - | -171 | -43 | -430 | -204 | -1,302 | Upgrade |
Changes in Inventories | - | -27 | 598 | -825 | -1,065 | -508 | Upgrade |
Changes in Accounts Payable | - | 212 | -500 | 648 | 479 | 59 | Upgrade |
Changes in Other Operating Activities | -1,148 | -393 | -592 | -442 | -758 | 1,356 | Upgrade |
Operating Cash Flow | 7,578 | 8,667 | 8,406 | 9,154 | 9,312 | 8,289 | Upgrade |
Operating Cash Flow Growth | -18.93% | 3.10% | -8.17% | -1.70% | 12.34% | 66.68% | Upgrade |
Capital Expenditures | -1,408 | -1,400 | -1,479 | -2,243 | -2,523 | -1,474 | Upgrade |
Sale of Property, Plant & Equipment | 50 | 57 | 87 | 24 | 20 | 8 | Upgrade |
Purchases of Investments | -1,929 | -3,396 | -208 | -52 | - | - | Upgrade |
Proceeds from Sale of Investments | - | 1,770 | 15 | 116 | - | - | Upgrade |
Payments for Business Acquisitions | - | -3,132 | -3,660 | -39 | -19,395 | -38 | Upgrade |
Other Investing Activities | 277 | 260 | 103 | 35 | -34 | -6 | Upgrade |
Investing Cash Flow | -4,373 | -5,841 | -5,142 | -2,159 | -21,932 | -1,510 | Upgrade |
Short-Term Debt Issued | - | - | 1,620 | 1,526 | 2,512 | 383 | Upgrade |
Short-Term Debt Repaid | - | - | -1,935 | -3,690 | - | -387 | Upgrade |
Net Short-Term Debt Issued (Repaid) | - | - | -315 | -2,164 | 2,512 | -4 | Upgrade |
Long-Term Debt Issued | - | 1,204 | 5,942 | 3,193 | 18,137 | 3,464 | Upgrade |
Long-Term Debt Repaid | -5,232 | -3,607 | -5,782 | -375 | -11,738 | -710 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -5,232 | -2,403 | 160 | 2,818 | 6,399 | 2,754 | Upgrade |
Repurchase of Common Stock | - | -4,000 | -3,000 | -3,000 | -2,000 | -1,500 | Upgrade |
Net Common Stock Issued (Repurchased) | - | -4,000 | -3,000 | -3,000 | -2,000 | -1,500 | Upgrade |
Common Dividends Paid | -610 | -583 | -523 | -455 | -395 | -337 | Upgrade |
Other Financing Activities | 53 | 195 | 56 | -9 | 65 | 46 | Upgrade |
Financing Cash Flow | -5,949 | -6,792 | -3,622 | -2,810 | 6,581 | 959 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 250 | -91 | -82 | -139 | 194 | 176 | Upgrade |
Net Cash Flow | -2,494 | -4,057 | -440 | 4,046 | -5,845 | 7,914 | Upgrade |
Beginning Cash & Cash Equivalents | 7,097 | 8,097 | 8,537 | 4,491 | 10,336 | 2,422 | Upgrade |
Ending Cash & Cash Equivalents | 4,603 | 4,040 | 8,097 | 8,537 | 4,491 | 10,336 | Upgrade |
Free Cash Flow | 6,170 | 7,267 | 6,927 | 6,911 | 6,789 | 6,815 | Upgrade |
Free Cash Flow Growth | -15.10% | 4.91% | 0.23% | 1.80% | -0.38% | 68.40% | Upgrade |
FCF Margin | 14.28% | 16.95% | 16.16% | 15.39% | 17.31% | 21.15% | Upgrade |
Free Cash Flow Per Share | 16.22 | 18.97 | 17.85 | 17.54 | 17.10 | 17.08 | Upgrade |
Levered Free Cash Flow | 1,667 | 5,432 | 7,273 | 8,123 | 15,361 | 10,883 | Upgrade |
Unlevered Free Cash Flow | 7,261 | 8,148 | 7,980 | 8,142 | 7,495 | 8,635 | Upgrade |
Updated Jun 28, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.